ESG Performance Report

Overview

The report describes GSK's 2022 ESG performance after the demerger of its Consumer Healthcare business to form Haleon. The company reports an ESG Performance Rating of "on track," with 83% of performance metrics met or exceeded. Highlights include reaching 73 million people with products in lower income countries, reducing Scope 1 and 2 carbon emissions by 6% compared with 2021, and reaching 73% renewable electricity.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview